An investment firm connected to US President Joe Biden's son Hunter Biden has been implicated1 in the financing of the Pentagon's military biological program in Ukraine, the head of Russia's Radiation, Chemical, and Biological Defence Troops has announced, citing fresh documents.
"Incoming materials have allowed us to trace the scheme of interaction between US government bodies and Ukraine's biolabs. The involvement in the financing of these activities by structures close to the current US leadership, in particular the Rosemont Seneca investment fund managed by Hunter Biden, draws attention to itself," RCBD Troops chief Igor Kirillov said in a briefing Thursday.
"The scale of the program is impressive. Along with the Pentagon, the US Agency for International Development (USAID), the Soros' Open Society Foundations, and the Centers for Disease Control and Prevention are directly involved in its implementation," the officer said. "Scientific supervision2 is carried out by leading research organizations, including the Los Alamos National Laboratory, which developed nuclear weapons for the Manhattan Project. All of this activity has been carried out under the direct control of the Pentagon."
Russia's Radiation, Chemical, and Biological Defence Troops have established that the US and its allies have exported about 16,000 biosamples from Ukraine as part of their military biological activities in the country.
Over 10,000 samples were sent to the Lugar Center in Georgia alone, according to Kirillov, with labs in the UK and the Leffler Institute in Germany also serving as recipients3, subjecting not only Ukraine but the entire region to dangers.
"Such large-scale screening of the natural immunity4 of the population was likely carried out in order to select biological agents that are most dangerous for the population of a particular region," Kirillov said.
Kirillov warned that the spread of pathogenic biomaterials in Ukraine could lead to a new pandemic, saying that in the Russian military's view, "the current situation involving the spread of pathogenic biomaterials from Ukraine to European countries can cause death and create a hotbed of epidemiological instability the scale of which would be comparable to the COVID-19 pandemic.